Efficacy
Among all participants, intent-to-treat 12-week postquit biochemically verified 30-day continuous smoking abstinence was 23 of 95 participants (24%) in the adaptive group and 8 of 93 participants (9%) in the standard treatment group (OR, 3.39; 95% CI, 1.43-7.99; 